Journal Article

Effect of routine seasonal malaria chemoprevention on malaria trends in children under 5 years in Dangassa, Mali

Diarra, Ayouba, Thiam, Sibe, Diawara, Sory I., Sissoko, Ibrahim, Traoré, Karim, Keita, Bourama, Diakité, Mahamadou, Sogoba, Nafomon, Krogtad, Donald J., Keita, Moussa, Guindo, Agnès, Diakité, Seidina A. S., Traoré, Sékou F., Konaté, Drissa, Doumbia, Seydou, Touré, Mahamoudou

2020

Overview

Background Seasonal malaria chemoprevention (SMC) is a new strategy to prevent malaria in children under 5 years old. It has been recommended by the World Health Organization since 2012 in malaria-endemic areas with seasonal transmission. This study aimed to assess the changes in malaria indicators through two consecutive years of SMC routine implementation in children under 5 years old in Dangassa, where malaria is endemic with a long and high transmission season. Methods From 2012 to 2016, a cohort study was conducted in Dangassa village. The study team based in the village followed all malaria clinical cases in children under 5 years old at the community health centre. During the study, SMC was routinely implemented in collaboration with the National Malaria Control Programme. The Cox regression model was used in order to compare malaria risk during the study. Results The Cox regression model showed a significant reduction in malaria clinical incidence, both in 2015 (HR = 0.27 (0.18–0.40), 95% CI) and in 2016 (HR = 0.23 (0.15–0.35), 95% CI) of SMC implementation compared to October 2013. Gametocyte and fever prevalence was lower between September and October during SMC implementation (2015 and 2016) compared to the same period before SMC implementation (2013–2014). A slight increase of malaria incidence was observed in December at the end of SMC implementation. Conclusion SMC has significantly reduced both malaria incidence and gametocyte prevalence and improved haemoglobin levels in children under 5 years old after 2 years of routine implementation.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: ACT now: anti-malarial market complexity one decade after the introduction of artemisinin combination therapy – evidence from sub-Saharan Africa and the Greater Mekong Sub-region / Analysis / Antimalarials - administration & dosage / Biomedical and Life Sciences / Biomedicine / Cancer prevention / Censuses / Chemoprevention - statistics & numerical data / Child, Preschool / Children / Cohort Studies / Cohorts / Disease transmission / Drug dosages / Endemic Diseases - prevention & control / Entomology / Epidemiology / Fever / Health Plan Implementation / Health risks / Hemoglobin / Human diseases / Humans / Infant / Infectious Diseases / Insecticides / Malaria / Malaria - epidemiology / Malaria - prevention & control / Malaria indicators / Mali / Mali - epidemiology / Microbiology / Minority & ethnic groups / NMCP / Parasitology / Prevalence / Prevention / Public Health / Pyrimethamine / Regression Analysis / Risk Factors / Seasons / SMC / Studies / Trends / Tropical Medicine / Vector-borne diseases / World Health Organization